Moderna: antibodies present 6 months after Covid vaccine

(CercleFinance.com) - Moderna has highlighted a study published in The New England Journal of Medicine showing the presence of antibodies against Covid-19 up to six months after the second dose of its vaccine.


"We are pleased that this new data shows antibody persistence through 6 months following the second dose of our COVID-19 vaccine," said Stéphane Bancel, Chief Executive Officer of Moderna. "This gives us further confidence in the protection afforded by our COVID-19 vaccine. We remain committed to continuing to address the COVID-19 pandemic."

Moderna said that studies monitoring immune responses beyond 6 months are currently being conducted.

As a precaution, the company is also pursuing a clinical development strategy against emerging coronavirus variants.


Copyright (c) 2021 CercleFinance.com. All rights reserved.